The expression of CD133 (Prominin-1), which is a surface glycoprotein linked to organ-specific stem cells and another marker for cancer stem cells, was described as a marker of cancer-initiating cells in different tumor types and was an independent predictor of poor prognosis of NSCLC [26,27,28]. This evidence concerns the gene PROM1 and neoplasm.